Anderson brings over 25 years of operational and financial leadership experience across the life sciences, technology, and retail industries Joseph R. Smith, CPA, CGMA, to retire in April 2022 TAMPA, FL -- M2GEN, a bioinformatics company accelerating discoveries in oncology research through industry leading data and analytics, today announced that Eric Anderson will join the company as new [...]

Woo bringing key manufacturing experience and turnaround time reductions to proteomic and glycomic-focused company Vector Laboratories, the pioneer of innovative proteomic and glycomic solutions, today announced that Kum Ming Woo has joined its executive team as Vice President, Operations. In this new role, he will oversee Vector Laboratories’ work in further innovating its manufacturing processes [...]

Tapestri Solution for Solid Tumor Research offers improved CNV analysis capability, in addition to breast cancer and glioblastoma research panels SOUTH SAN FRANCISCO, Calif. – Mission Bio, Inc., the pioneer in high-throughput single-cell DNA and multi-omics analysis, today launched the Tapestri Solution for Solid Tumor Research. This new end-to-end single-cell DNA sequencing workflow on the Tapestri Platform [...]

Ion Torrent Genexus Dx Integrated Sequencer enables rapid NGS for diagnostic applications and clinical research CARLSBAD, Calif.  -- Thermo Fisher Scientific today launched the CE-IVD marked Ion Torrent Genexus Dx Integrated Sequencer, an automated, next-generation sequencing (NGS) platform that delivers results in as little as a single day. Designed for use in clinical laboratories, the fully [...]

Ampersand investment opportunity Syft is pleased to announce that it has reached an agreement with Ampersand Capital Partners (Ampersand) to invest $22.8m in Syft, subject to shareholder approval. Ampersand will subscribe to 17,545,000 convertible preference shares, equivalent to 19.6% of the total shares post-investment, at a price of $1.30 per share. Ampersand is a Boston, [...]

Cambridge, UK – Cresset Discovery, provider of CADD expertise for drug discovery, is collaborating with the Translation team at The Francis Crick Institute as expert computational chemist in residence. Computational chemistry is a powerful method in tool development and drug discovery. It enables chemists to predict the physical properties and biological activity of compounds prior to synthesis [...]

Fully silent Fc-engineered antibodies accessible for therapeutic antibody development REDCAR and OXFORD, United Kingdom -- Absolute Antibody Ltd., an industry-leading provider of recombinant antibody products and services, and mAbsolve, developers of a novel Fc silencing variant, today announced a licensing deal for mAbsolve's Fc silencing technology. The agreement provides Absolute Antibody clients with easy license-free access to the new STR [...]

Asynt has introduced a new modular version of its popular LightSyn Illumin8 photoreactor. This innovative system provides researchers with the flexibility to change quickly and safely between a selection of high-power light emitting diodes (LEDs) operating at wavelengths including UV (365 nm) and blue (450 nm). The LightSyn Illumin8 allows chemists to run up to 8 [...]

TOKYO: FUJIFILM Corporation (President and CEO, Representative Director: Teiichi Goto) today announced that FUJIFILM Irvine Scientific, Inc., a world leader in the development and manufacture of serum-free and chemically defined cell culture media for life science research, bioproduction, and cell therapy manufacturing, completed the acquisition of Shenandoah Biotechnology, Inc., a leading manufacturer of recombinant proteins. [...]

Life science research distributor Nordic BioSite Group brings in new majority owner Adelis Equity Partners in order to further accelerate its growth and geographic expansion with the goal of becoming an even stronger partner to its suppliers and customers Nordic BioSite Group (NBG) is a leading European supplier of research and diagnostics products, with a [...]